![]() In 2013, the makers of Opana and Opana ER, Endo Pharmaceuticals. Grassley added that drug companies are still entering into agreements to stall drug competition, "leaving consumers to pay higher prices for prescription medications."īranded drugs typically lose up to 90 percent of their market share once a generic comes onto the market. The Opana brand name has been discontinued in the U.S. The FTC's actions "are an important step in ending pay-off agreements that allow drug manufacturers to rake in huge profits while keeping cheaper generic drugs off the market," Klobuchar said. Federal Trade Commission finding the reverse payment settlement agreement between Endo Pharmaceuticals (Endo) and Impax Laboratories LLC (Impax) violated. and several other drug companies violated antitrust laws by using pay-for-delay settlements to block consumers' access to lower-cost generic versions of Lidoderm. Senator Amy Klobuchar, a Democrat, and Republican Senator Chuck Grassley said in a statement that they have introduced legislation, "Preserve Access to Affordable Generics Act," to crack down on such arrangements. Case Summary The FTC's complaint alleges that Endo Pharmaceuticals Inc. A spokesman for Impax was not immediately reachable. Watson, which was formerly owned by Allergan Plc (AGN.N), is now owned by Teva Pharmaceutical Industries Ltd (TEVA.TA). The complaint against those companies remains outstanding. Attorney General Reyes Joins Coalition in Lawsuit Against US AG and the ATF on Pistol. Watson and Impax were also named in the FTC's lawsuit, which alleges the companies illegally blocked access to low-cost alternatives to Endo's products. FTC and Utah Division of Consumer Protection Suit Leads to Largest. It said the settlement is "consistent with the company's position that the Lidoderm and Opana ER settlements fully complied with the law both at the time they were executed and today." ![]() in the antitrust multidistrict litigation against Endo Pharmaceuticals. The proposed settlement must be ratified by a court.Įndo said it is not required to make any monetary payment to the FTC and made no admission of liability. See also FTC Press Release, FTC Sues Endo Pharmaceuticals Inc. The agency also alleged Endo paid Watson Laboratories Inc to delay introduction of a generic version of its Lidoderm pain treatment.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |